TACROLIMUS 0.1% IN PSEUDOCATALASE cream

TACROLIMUS 0.1% IN PSEUDOCATALASE by

Drug Labeling and Warnings

TACROLIMUS 0.1% IN PSEUDOCATALASE by is a Prescription medication manufactured, distributed, or labeled by Sincerus Florida, LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Directions for use

Sincerus Florida, LLC adverse reactions.

Active, inactive

NDC:

72934-2174-2 / TACROLIMUS USP 0.1%. Cream 30gm

INGREDIENTS AND APPEARANCE

TACROLIMUS 0.1% IN PSEUDOCATALASE 
tacrolimus 0.1% in pseudocatalase cream

Product Information
Product Type	HUMAN PRESCRIPTION DRUG	Item Code (Source)	NDC: 72934-2174
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
TACROLIMUS (UNII: WM0HAQ4WNM) (TACROLIMUS ANHYDROUS - UNII:Y5L2157C4J)	TACROLIMUS ANHYDROUS	0.1 g  in 100 g

Product Characteristics
Color	white	Score
Shape		Size
Flavor		Imprint Code
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 72934-2174-2	30 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product	05/01/2019

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		05/01/2019

Labeler - Sincerus Florida, LLC (080105003)

Establishment
Name	Address	ID/FEI	Business Operations
Sincerus Florida, LLC		080105003	manufacture(72934-2174)